The management of difficult-to-treat acute and chronic respiratory infections (infections in
cystic fibrosis, non-cystic fibrosis bronchiectasis, immunocompromised and mechanically …

Inhaled antibiotics have been used to treat chronic airway infections since the 1940s. The
earliest experience with inhaled antibiotics involved aerosolizing antibiotics designed for …

The in vitro release study is a critical test to assess the safety, efficacy, and quality of
nanoparticle-based drug delivery systems, but there is no compendial or regulatory …

The characterization of encapsulation efficiency and in vitro drug release from nanoparticle-
based formulations often requires the separation of nanoparticles from unencapsulated …

Despite the popularity of chitosan as a biodegradable polymer used in a variety of
applications, clinical trials involving chitosan or its nanoparticles are still scarce. Moreover …

The lungs have received attention as a portal for drug delivery in tuberculosis (TB) from
researchers addressing diverse objectives. These include:(a) targeting alveolar …

Paeonol shows effective anti-allergic, anti-inflammatory and analgesic activities. However,
because of its poor solubility in water and high volatility at room temperature, the application …

The treatment and management of tuberculosis using conventional drug delivery systems
remain challenging due to the setbacks involved. The lengthy and costly treatment regime …

From the early sixteenth and seventeenth centuries to the present day of life, tuberculosis
(TB) still is a global health threat with some new emergence of resistance. This type of …

The effects of lipid composition and preparation conditions on the physicochemical and
technological properties of gemcitabine-loaded liposomes, as well as the in vitro anti …